About Knome
Knome is a company based in Cambridge (United States) founded in 2007 was acquired by Tute Genomics in November 2015. It operates as a SaaS (Software-as-a-Service), and Professional Services. Knome has raised $25 million across 5 funding rounds from investors including Tute Genomics. The company has 18 employees as of December 31, 2014. Knome offers products and services including knoSYS and knomeDISCOVERY. Knome operates in a competitive market with competitors including DNAnexus, Genomics, Depixus, Seven Bridges Genomics and Ingenuity Systems, among others.
- Headquarter Cambridge, United States
- Employees 18 as on 31 Dec, 2014
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Knome Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$25 M (USD)
in 5 rounds
-
Latest Funding Round
$13 M (USD), Series B
Jan 10, 2014
- Investors
-
Employee Count
18
as on Dec 31, 2014
-
Acquired by
Tute Genomics
(Nov 02, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Knome
Knome offers a comprehensive portfolio of products and services, including knoSYS and knomeDISCOVERY. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A system for analyzing and interpreting genomic data.
End-to-end solution for studying human genomic data.
Funding Insights of Knome
Knome has successfully raised a total of $25M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $13 million completed in January 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $13.0M
-
First Round
First Round
(25 Nov 2008)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2014 | Amount | Series B - Knome | Valuation |
investors |
|
| Oct, 2013 | Amount | Debt – Conventional - Knome | Valuation |
investors |
|
| Jul, 2011 | Amount | Series A - Knome | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Knome
Knome has secured backing from 1 investor. Prominent investors backing the company include Tute Genomics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cloud-based genome analysis for precision medicine is provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Knome
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Knome
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Knome Comparisons
Competitors of Knome
Knome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Genomics, Depixus, Seven Bridges Genomics and Ingenuity Systems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud-based genome informatics and data management are provided.
|
|
| domain | founded_year | HQ Location |
Genomic risk assessment and prevention platform is provided.
|
|
| domain | founded_year | HQ Location |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| domain | founded_year | HQ Location |
Genomic data is analyzed and interpreted via web-based applications.
|
|
| domain | founded_year | HQ Location |
Platforms for genomic data analysis and management are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Knome
When was Knome founded?
Knome was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Where is Knome located?
Knome is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Knome a funded company?
Knome is a funded company, having raised a total of $25M across 5 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Nov 25, 2008.
How many employees does Knome have?
As of Dec 31, 2014, the latest employee count at Knome is 18.
What does Knome do?
Knome is involved in delivering bioinformatics infrastructure and insights for translational genomics initiatives. The company supports clinical NGS testing programs through scalable informatics systems like knoSYS for genome and exome data analysis. Additionally, research services such as knomeDISCOVERY are offered to pharmaceutical and academic researchers for studying large-scale human genomic data. Solutions are tailored to empower partners in advancing pharmaceutical success across healthcare and biotechnology sectors.
Who are the top competitors of Knome?
Knome's top competitors include DNAnexus, Depixus and Ingenuity Systems.
What products or services does Knome offer?
Knome offers knoSYS and knomeDISCOVERY.
Who are Knome's investors?
Knome has 1 investor. Key investors include Tute Genomics.